 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Compensation Committee of the Board of Ajanta Pharma Ltd has at its meeting held today has allotted 1,000 fully paid up equity shares of Rs. 2/- each, upon exercise of options. In view of the above, the paid up capital of the Company stands increased to Rs. 17,60,12,000 consisting 8,80,06,0000 equity shares of Rs. 2/- each.
The committee has granted further options under Employees Stock Option Scheme - 2011 (ESOS SCHEME 2011). Total number of options granted was 2,000 and the number of shares covered under options - 1 share per option. The Exercise Period is one month from vesting date Company will be making application for listing of these shares in due course.
Shares of AJANTA PHARMA LTD. was last trading in BSE at Rs.1603 as compared to the previous close of Rs. 1580.15. The total number of shares traded during the day was 14746 in over 918 trades.
The stock hit an intraday high of Rs. 1612.95 and intraday low of 1555. The net turnover during the day was Rs. 23224872.